The RNA Interference Effector Protein Argonaute 2 Functions as a Restriction Factor Against SARS-CoV-2

Area of Science:

• Molecular Biology
• Virology
• Gene Regulation

Background:

• The RNA interference (RNAi) pathway, mediated by Argonaute 2 (Ago2), regulates gene expression using small RNAs.
• While known for antiviral defense in invertebrates and plants, Ago2's role in mammalian antiviral immunity is less understood.

Purpose of the Study:

• To investigate the function of Argonaute 2 (Ago2) in restricting the replication of SARS-CoV-2, the virus causing COVID-19.
• To determine the mechanisms underlying Ago2's antiviral activity against coronaviruses.

Main Methods:

• Microscopic analysis of SARS-CoV-2 infected cells to observe Ago2 localization.
• Gene ablation studies in cells lacking Ago2 to assess viral replication.
• Assessing viral replication in cells lacking Dicer.
• Deep sequencing to identify viral small RNAs interacting with Ago2.

Main Results:

• Ago2 localizes to SARS-CoV-2 replication sites and its absence increases viral titers over 1,000-fold.
• Ago2's antiviral activity requires both small RNA binding and endonuclease function, independent of Dicer.
• A SARS-CoV-2 mutant lacking a specific viral miRNA was less sensitive to Ago2 restriction.

Conclusions:

• Ago2 acts as a potent antiviral factor against SARS-CoV-2 in mammalian cells.
• Ago2-small viral RNA complexes likely target and cleave viral RNA at replication sites.
• The findings suggest a Dicer-independent RNAi mechanism for restricting coronavirus replication.